Enhanced recovery protocols in colonic surgery: retrospective cohort analysis of economic impact from an institutional point of view.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Feb 2019
Historique:
accepted: 14 11 2018
pubmed: 22 11 2018
medline: 30 4 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

Despite increasing evidence supporting the beneficial effects of enhanced recovery protocols (ERPs), their accurate economic impact on institutions remains lacking. The aim of this study was to analyze ERP economic impact in a French center in order to further encourage implementation. All patients who underwent elective laparoscopic right or left colectomy for benign or malignant pathology from 2014 to 2017 in a single center were retrospectively reviewed. ERP according to national recommendations was effective starting November 2015. Perioperative data and all direct costs borne by the institution were collected for each patient. Patients who underwent colectomy before and after ERP implementation were compared. Overall, 288 patients were included of which 144 received conventional perioperative care (CC) and 144 received ERP. There were 161 (56%) men, median age was 71 (28-92) years, and 242 (84%) patients underwent surgery for malignant disease. Operative time, intraoperative blood loss, and severe postoperative complications were similar between both groups. ERP was associated with reduced Clavien-Dindo I-II postoperative complications (15% vs. 28%, p = 0.010) and overall in-hospital stay (6 vs. 7 days, p = 0.003). Overall institutional costs were lower in the ERP group although difference was not statistically significant (7022 vs. 7501 euros, p = 0.098). Estimated savings per patient reached a mean of 480 euros. In a tertiary French center, ERP was associated with reduced postoperative morbidity and in-hospital stay resulting in considerable cost savings. Although not significant, ERP resulted in positive economic impact even in an early implementation phase.

Sections du résumé

BACKGROUND BACKGROUND
Despite increasing evidence supporting the beneficial effects of enhanced recovery protocols (ERPs), their accurate economic impact on institutions remains lacking. The aim of this study was to analyze ERP economic impact in a French center in order to further encourage implementation.
METHODS METHODS
All patients who underwent elective laparoscopic right or left colectomy for benign or malignant pathology from 2014 to 2017 in a single center were retrospectively reviewed. ERP according to national recommendations was effective starting November 2015. Perioperative data and all direct costs borne by the institution were collected for each patient. Patients who underwent colectomy before and after ERP implementation were compared.
RESULTS RESULTS
Overall, 288 patients were included of which 144 received conventional perioperative care (CC) and 144 received ERP. There were 161 (56%) men, median age was 71 (28-92) years, and 242 (84%) patients underwent surgery for malignant disease. Operative time, intraoperative blood loss, and severe postoperative complications were similar between both groups. ERP was associated with reduced Clavien-Dindo I-II postoperative complications (15% vs. 28%, p = 0.010) and overall in-hospital stay (6 vs. 7 days, p = 0.003). Overall institutional costs were lower in the ERP group although difference was not statistically significant (7022 vs. 7501 euros, p = 0.098). Estimated savings per patient reached a mean of 480 euros.
CONCLUSIONS CONCLUSIONS
In a tertiary French center, ERP was associated with reduced postoperative morbidity and in-hospital stay resulting in considerable cost savings. Although not significant, ERP resulted in positive economic impact even in an early implementation phase.

Identifiants

pubmed: 30460474
doi: 10.1007/s00384-018-3201-9
pii: 10.1007/s00384-018-3201-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-307

Références

JAMA. 1999 Oct 20;282(15):1458-65
pubmed: 10535437
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Arch Surg. 2005 Mar;140(3):278-83, discussion 284
pubmed: 15781793
Br J Surg. 2007 Feb;94(2):224-31
pubmed: 17205493
Clin Nutr. 2010 Aug;29(4):434-40
pubmed: 20116145
Arch Surg. 2011 May;146(5):571-7
pubmed: 21242424
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007635
pubmed: 21328298
Ann Surg Oncol. 2012 Dec;19(13):4168-77
pubmed: 22805866
World J Surg. 2013 Feb;37(2):259-84
pubmed: 23052794
Dis Colon Rectum. 2013 May;56(5):667-78
pubmed: 23575408
Ann Surg. 2014 Apr;259(4):670-6
pubmed: 23673770
Br J Surg. 2013 Jul;100(8):1108-14
pubmed: 23754650
Colorectal Dis. 2014 May;16(5):338-46
pubmed: 24283942
World J Surg. 2014 Jun;38(6):1531-41
pubmed: 24368573
J Visc Surg. 2014 Feb;151(1):65-79
pubmed: 24378143
Ann Surg. 2015 Dec;262(6):1026-33
pubmed: 25371130
Health Serv Manage Res. 2013 Aug;26(2-3):86-94
pubmed: 25595005
Int J Surg. 2015 Sep;21:75-81
pubmed: 26231994
Surgery. 2016 Mar;159(3):700-12
pubmed: 26435444
J Visc Surg. 2016 Dec;153(6S):S41-S44
pubmed: 27789266
JAMA Surg. 2017 Mar 1;152(3):292-298
pubmed: 28097305
Lancet. 1995 Mar 25;345(8952):763-4
pubmed: 7891489

Auteurs

Amel Benbouzid (A)

Department of Pharmacy, Institut Mutualiste Montsouris, Paris, France.
Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Nicolas Tabchouri (N)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Christine Denet (C)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Jean-Marc Ferraz (JM)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Anais Laforest (A)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Brice Gayet (B)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Candice Tubbax (C)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Pascal Paubel (P)

Health Law Institute, INSERM UMR S1145, Paris Descartes University, Sorbonne Paris Cité, Paris, France.

Ariane d'Avout d'Auerstaedt (A)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France.

Anne-Elisabeth Bossard (AE)

Department of Anesthesiology, Institut Mutualiste Montsouris, Paris, France.

Anthony Sarran (A)

Department of Radiology, Institut Mutualiste Montsouris, Paris, France.

Isabelle Aminot (I)

Department of Medical information, Institut Mutualiste Montsouris, Paris, France.

Sandra Camps (S)

Department of Pharmacy, Institut Mutualiste Montsouris, Paris, France.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, 42 boulevard Jourdan, 75014, Paris, France. david.fuks@imm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH